Skip to main content
SpringerLink
Log in

Effekt von Fenofibrat auf die Nierenfunktion bei Patienten mit Diabetes mellitus Typ 2

Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus

  • Für Sie gelesen
  • Published:
Der Diabetologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. The FIELD Study Investigators (2005) Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD Study): randomised controlled trial. Lancet 366:1849–1861

    Article  Google Scholar 

  2. The ACCORD Study Group (2010) Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 362:1563–1574

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Praxis im Klosterhof, Klosterhofstr. 1, 8280, Kreuzlingen, Schweiz

    V. Pavlicek

Authors
  1. V. Pavlicek
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. Pavlicek.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pavlicek, V. Effekt von Fenofibrat auf die Nierenfunktion bei Patienten mit Diabetes mellitus Typ 2. Diabetologe 7, 115–116 (2011). https://doi.org/10.1007/s11428-011-0691-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11428-011-0691-2

Search

Navigation